Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants

European Journal of Pediatrics

Volumn 159, Issue 5, 2000, Pages 364-368

  De Carolis, Maria Pia ^a   Romagnoli, Constantino ^a   Polimeni, Valentina ^a   Piersigilli, Fiammetta ^a   Zecca, Enrico ^a   Papacci, Patrizia ^a   Delogu, Angelica Bibiana ^a   Tortorolo, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Ibuprofen; Indomethacin; Patent ductus arteriosus; Preterm neonates

Indexed keywords

IBUPROFEN; INDOMETACIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; MALE; NEWBORN; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 0034014640     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310051288     Document Type: Article

References (28)

1. 1. Alpan G, Clyman RI (1995) Cardiovascular effect of surfactant replacement with special reference to the patent ductus arteriosus. In: Robertson B, Tausch HW (eds). Surfactant therapy for lung disease: lung biology in health and disease. Marcel Dekker, New York, pp 531-545
2. 2. Aranda JV, Varvarigou A, Beharry K, Bansal R, Bardin CL, Modanlou H, Papageorgiou A, Chemtob S (1997) Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant. Acta Pediatr 86: 289-293
3. 3. Bancalari E, Abdenour GE, Feller R, Gannon J (1979) Bronchopulmonary dysplasia: clinical presentation. J Pediatr 95: 819-23
4. 4. Chemtob S, Beharry K, Barna T, Varma DR, Aranda JV (1991) Differences in the effects in the newborn piglet of various nonsteroidal anti-inflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins. Pediatr Res 30: 106-111
5. 5. Clyman RI (1996) Recommendation for the postnatal use of indomethacin: an analysis of four separate treatment strategies. J Pediatr 128: 601-607
6. 6. Coceani F, White E, Bodach E, Olley PM (1979) Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen. Can J Physiol Pharmacol 57: 825-831
7. 7. Cooper-Peel C, Brodersen R, Robertson A (1996) Does ibuprofen affect bilirubin-albumin binding in newborn infant serum? Pharmacol Toxicol 79: 297-299
8. 8. Couser RJ, Ferrara TB, Wright GB, Cabalka AK, Schilling CG, Hoekstra RE, Payne NR (1996) Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room. J Pediatr 128: 631-637
9. 9. De Vries LS, Eken P, Dubowitz LMS (1992) The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res 49: 1-6
10. 10. Dudell G, Gersony M (1984) Patent ductus arteriosus in neonates with severe respiratory disease. J Pediatr 104: 915-920
11. 11. Fowlie PW (1996) Prophylactic indomethacin: systematic review and meta-analysis. Arch Dis Child 74: F81-F87
12. 12. Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE (1976) Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med 95: 526-529
13. 13. Hanna N, Lachapelle P, Roy MS, Orquin J, Varma DR, Chemtob S (1995) Alterations in the electroretinogram of newborn piglets by propionic acid-derivate non steroidal antiinflammatory drugs but not by indomethacine and diclofenac. Pediatr Res 37: 81-85
14. 14. Kääpä P, Seppänen M, Kero P, Saraste M (1993) Pulmonary hemodynamics after synthetic surfactant replacement in neonatal distress syndrome. J Pediatr 123: 115-119
15. 15. Maggio L, Gallini F, De Carolis MP, Frezza S, Greco F (1994) Rendimento calorico della NP nel neonato di peso molto basso. Minerva Pediatr 46: 421-427
16. 16. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C (1997) Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 131: 549-554
17. 17. Papile LA, Burstein J, Burstein R, Koffler H (1978) Incidence and evaluation of subependymal and intraventricular haemorrhage: a study of infants with birth weight less than 1500 g. J Pediatr 92: 529-534
18. 18. Patel J, Marks KA, Roberts I, Azzopardi D, Edwards AD (1995) Ibuprofen treatment of patent ductus arteriosus. Lancet 346: 255
19. 19. Stoll BJ (1994) Epidemiology of necrotising enterocolitis. Clin Perinatol 21: 205-218
20. 20. Troche B, Harvey-Wilkes K, Engle WD, Nielsen HC (1995) Early minimal feedings promote growth in critically ill premature Biol Neonate. 67: 172-181
21. 21. Van Bel F, Gerard L, Schipper J, van de Bor M, Baan J (1991) Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging. J Pediatr 118: 621-626
22. 22. Van Bel F, van de Bor M, Stijnen T, Baan J, Ruys JH (1989) Cerebral blood flow velocity changes in preterm infants infants after a single dose of indomethacin: duration of its effect. Pediatrics 84: 802-807
23. 23. Van Bel F, Van Zoeren D, Schipper J, Guit G, Baan J (1990) Effect of indomethacin on superior mesenteric artery blood flow velocity in preterm infants, J Pediatr 116: 965-970
24. 24. Van Overmeire B, Pollens I, Hartmann S, Creten WL, Van Acker KJ (1997) Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child 76: F179-F184
25. 25. Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV (1996) Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 275: 539-544
26. 26. Varvarigou A, Beharry K, Bardin CL, Chemtob S, Papageorgiou A, Aranda JV (1995) Early closure of patent ductus arteriosus (PDA) by intravenous (IV) ibuprofen in premature newborns. Pediatr Res 35: 259A
27. 27. Weiss H, Bruce C, Brook M, Schueter M, Clyman R (1995) Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin. J Pediatr 127: 466-471
28. 28. Yanowitz TD, Yao AC, Werner JC, Pettigrew KD, Oh W, Stonestreet BS (1996) Effects of prophylactic low-dose indomethacin on hemodynamics in very low birth weight infants. J Pediatr 131: 28-34